Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHSE: 688806)
Health Care · Biotechnology · CN
CN¥27.03
-3.29% today · -40.1% 1Y
Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHSE: 688806) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.85B.
Over the last twelve months the share price has lost 40.1%, trading between 23.28 and 52.52.
688806 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.85B
- Revenue (TTM)
- $11.02M
- P/E
- —
- EPS
- -1.33
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- CN¥52.52
- 52-week low
- CN¥23.28
- Avg volume (3M)
- —
- Shares outstanding
- 460.55M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.